Sensitization to the conditioned rewarding effects of morphine and cocaine: Differential effects of the κ-opioid receptor agonist U69593

European Journal of Pharmacology

Volumn 345, Issue 1, 1998, Pages 27-34

  Shippenberg, Toni S ^a   Lefevour, Anthony ^a   Thompson, Alexis C ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Opioid receptor; Behavioral sensitization; Cocaine; Morphine

Indexed keywords

COCAINE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; BENZENEACETAMIDES; COCAINE; CONDITIONING, OPERANT; CUES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; NARCOTICS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; REWARD;

EID: 0032510585     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01614-2     Document Type: Article

References (39)

1. Ackerman J.M., White F.J. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117:1990;181-187.
2. Acri, J.B., Heidbreder, Ch., Thompson, A.C., Pani, A.K., Shippenberg, T.S., 1996. The κ-opioid receptor agonist, U69593, modifies cocaine but not quinpirole-induced alterations in striatal dopamine. Proceedings of the 26th Annual Meeting of the Society of Neuroscience, Washington, DC, 1928, p. 22.
3. Davis W.M., Smith S.G. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlovian J. Biol. Sci. 11:1975;1151-1152.
4. Di Chiara G., Imperato A. Opposite effects of μ and κ-opioid receptor agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
5. Ehrman R.N., Robbins S.J., Childress A.R., O'Brien C. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology. 107:1992;523-529.
6. Fukagawa Y., Katz J.L., Suzuki T. Effects of a selective κ-opioid agonist, U-50,488H, on morphine dependence in rats. Eur. J. Pharmacol. 170:1989;47-51.
7. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., Costa M., Babbini M. Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology. 103:1991;183-189.
8. Gawin F.H., Kleber H.D. Abstinence symptomology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry. 43:1986;107-113.
9. Hadfield M.G., Nugent E.A. Comparative effect on dopamine uptake in extrapyramidal and limbic systems. Biochem. Pharmacol. 32:1983;744-746.
10. Heidbreder C.A., Shippenberg T.S. U69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. NeuroReport. 5:1994;1797-1800.
11. Heidbreder C.A., Goldberg S.R., Shippenberg T.S. The κ-opioid receptor agonist U69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616:1993;335-338.
12. Heidbreder C.A., Babovic-Vuksanovic, Shoaib M., Shippenberg T.S. Development of behavioral sensitization to cocaine: influence of kappa-opioid receptor agonists. J. Pharmacol. Exp. Ther. 275:1995;150-163.
13. Heidbreder C.A., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278:1996;490-502.
14. Hurd Y., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
15. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
16. 2 receptors. Synapse (in press).
17. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization. Brain Res. Rev. 16:1991;223-244.
18. 3H]-U69593, a highly selective ligand for the κ-opioid receptor. Eur. J. Pharmacol. 109:1985;281-284.
19. Lett B.T. Repeated exposure intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacology. 98:1989;357-362.
20. Livezey R.T., Pearce L.B., Kornetsky C. The effect of MK-801 and SCH 23390 on the expression and sensitization of morphine-induced oral stereotypy. Brain Res. 692:1995;93-98.
21. Maisonneuve I.M., Archer S., Glick S.D. U50,488, a κ-opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181:1994;57-60.
22. Mclellan A.T., Childress A.R., Ehrmann R., O'Brien C.P. Extinguishing conditioned responses during opiate dependence treatment: turning laboratory findings into clinical procedures. J. Subst. Abuse Treat. 3:1986;33-40.
23. Mucha R.F., Van der Kooy D., O'Shaughnessy P., Bucenieks A. Drug reinforcement studies by the use of place conditioning in the rat. Brain Res. 243:1982;91-105.
24. Nomikos G., Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology. 94:1988;119-125.
25. O'Brien C.P., Childress A.R., Mclellan T., Ehrmann R. Integrating systematic cue exposure with standard treatment in recovering drug-dependent patients. Addictive Behav. 15:1990;355-365.
26. 1 receptors in morphine-induced stereotypic behavior. Neurosci. Lett. 102:1989;291-296.
27. Robinson T.E., Berridge K.C. The neural basis of drug-craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
28. Shippenberg T.S., Heidbreder Ch. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal aspects. J. Pharmacol. Exp. Ther. 273:1995;808-815.
29. Shippenberg T.S., Stein C., Huber A., Herz A. Motivational effects of opioids in an animal model of prolonged inflammatory pain: Alteration in the effects of kappa- but not mu-opioid agonists. Pain. 35:1988;179-186.
30. Shippenberg T.S., Le Fevour A., Heidbreder Ch. κ-opioid agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol Exp. Ther. 276:1996;545-554.
31. Shippenberg T.S., Heidbreder Ch., Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299:1996;33-39.
32. Spanagel R., Shippenberg T.S. Modulation of morphine-induced sensitization by endogenous kappa-opioid systems. Neurosci. Lett. 153:1993;232-236.
33. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2046-2050.
34. Spanagel R., Almeida O.F.X., Bartl C., Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology. 115:1994;121-127.
35. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-313.
36. Suzuki T., Narita M., Takahashi Y., Misawa M., Nagase H. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol. 213:1992;91-97.
37. Trujillo K., Akil H. Opiate tolerance and dependence: recent findings and synthesis. New Biol. 3:1991;915-923.
38. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. NeuroReport. 5:1994;1613.
39. Weiss F., Paulus M.P., Lorang M.T., Koob G.F. Increases in extracellular dopamine in the nucleus accumbens are inversely related to basal levels: effects of acute and repeated administration. J. Neurosci. 12:1992;4372-4380.